IMR Press / CEOG / Volume 43 / Issue 4 / DOI: 10.12891/ceog3038.2016

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Case Report
Uterine arteriovenous fistula after perforation during the placement of an intrauterine device – Minimally invasive treatment using uterine artery embolization
Show Less
1 Department of Gynecology, Sugisawa Medical Center, Curitiba, Paraná
2 Department of Vascular Surgery Instituto da Circulação, Curitiba, Paraná; Marcelino Champagnat Hospital, Curitiba, Paraná (Brazil)
Clin. Exp. Obstet. Gynecol. 2016, 43(4), 602–605; https://doi.org/10.12891/ceog3038.2016
Published: 10 August 2016
Abstract

Uterine arteriovenous fistula (AVF) is a rare, but potentially life-threatening condition. Acquired fistulae may occur as a result of trauma or instrumentation, endometrial carcinoma, gestational trophoblastic disease, and intrauterine devices (IUDs). Herein the authors present the case of a 33-year-old woman with a uterine AVF developing after uterine perforation during the placement of a levonorgestrel IUD. The fistula was diagnosed using color Doppler ultrasonography and angiography and the treatment was conducted by minimally invasive approach using uterine artery embolization.
Keywords
Uterine arteriovenous malformation
Arteriovenous fistula
Intrauterine device
Uterine artery embolization
Share
Back to top